We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$604M
1-Year Est. Return
96.57%
This Fund
S&P 500
This Quarter
Est. Return
-2.52%
1 Year Est. Return
+96.57%
3 Year Est. Return
+564.25%
5 Year Est. Return
+486.18%
10 Year Est. Return
+2,856.71%
AUM
$196M
AUM Growth
-$77.5M
(-28%)
Cap. Flow
-$87.5M
Cap. Flow
% of AUM
-44.72%
Top 10 Holdings %
Top 10 Hldgs %
56.4%
Holding
63
New
21
Increased
5
Reduced
15
Closed
19
Avg Time Held Equity + Options
1.5
quarters
Top 10 Avg Time Held Equity + Options
1.2
quarters
Top 20 Avg Time Held Equity + Options
1
quarter
Avg Time Held Equity only
1.9
quarters
Top 10 Avg Time Held Equity only
1.2
quarters
Top 20 Avg Time Held Equity only
1.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$16.1M |
| 2 |
Medtronic
MDT
|
+$6.07M |
| 3 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$4.21M |
| 4 |
Abbott
ABT
|
+$4.16M |
| 5 |
Cardinal Health
CAH
|
+$2.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$12.9M |
| 2 |
SHPG
Shire pic
SHPG
|
+$10.9M |
| 3 |
Eli Lilly
LLY
|
+$10.1M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$9.65M |
| 5 |
AGN
Allergan plc
AGN
|
+$9.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 65.65% |
| 2 | Miscellaneous | 32.43% |
| 3 | Industrials | 1.3% |
| 4 | Consumer Discretionary | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
QTNT
1
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $18.1M | 9.24% |
58,346
-983
| -2% | -$375K |
2014 Q4
6 quarters
|
|
|
2
Biogen
BIIB
$33.8B
| $14.8M | 7.54% |
+61,000
| New | +$16.1M |
2016 Q2
0 quarters
|
|
|
CERN
3
PUT
DELISTED
Cerner Corp
CERN
| $13.5M | 6.89% |
+230,000
| New | +$12.8M |
2016 Q2
0 quarters
|
|
|
4
Cardinal Health
CAH
$55.5B
| $13.3M | 6.79% |
170,404
+35,771
| +27% | +$2.85M |
2016 Q1
1 quarter
|
|
|
ATHN
5
PUT
DELISTED
Athenahealth, Inc.
ATHN
| $11.5M | 5.86% |
83,100
+73,100
| +731% | +$9.67M |
2016 Q1
1 quarter
|
|
6
Philips
PHG
$24.3B
| $8.59M | 4.39% |
464,872
+73,298
| +19% | +$1.42M |
2016 Q1
1 quarter
|
|
7
Sanofi
SNY
$93.7B
| $8.37M | 4.28% |
200,000
-4,655
| -2% | -$191K |
2015 Q3
3 quarters
|
|
|
NEOS
8
DELISTED
Neos Therapeutics, Inc
NEOS
| $7.86M | 4.02% |
847,127
-442,896
| -34% | -$4.22M |
2015 Q3
3 quarters
|
|
|
ANTH
9
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $7.83M | 4% |
316,946
-65,079
| -17% | -$1.84M |
2015 Q2
4 quarters
|
|
10
PUT
Johnson & Johnson
JNJ
$599B
| $6.67M | 3.41% |
55,000
-45,000
| -45% | -$5.11M |
2016 Q1
1 quarter
|
|
|
11
Medtronic
MDT
$119B
| $6.51M | 3.32% |
+75,000
| New | +$6.07M |
2016 Q2
0 quarters
|
|
12
PUT
Pfizer
PFE
$162B
| $6.34M | 3.24% |
+189,720
| New | +$6.06M |
2016 Q2
0 quarters
|
|
13
CALL
Amgen
AMGN
$223B
| $6.09M | 3.11% |
+40,000
| New | +$6.22M |
2016 Q2
0 quarters
|
|
|
14
Amgen
AMGN
$223B
| $5.48M | 2.8% |
36,000
-41,721
| -54% | -$6.49M |
2016 Q1
1 quarter
|
|
|
HRC
15
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $4.22M | 2.15% |
+83,600
| New | +$4.21M |
2016 Q2
0 quarters
|
|
|
TSRO
16
PUT
DELISTED
TESARO, Inc.
TSRO
| $4.2M | 2.15% |
+50,000
| New | +$2.23M |
2016 Q2
0 quarters
|
|
|
17
Abbott
ABT
$178B
| $4.11M | 2.1% |
+104,550
| New | +$4.16M |
2016 Q2
0 quarters
|
|
18
PUT
Novo Nordisk
NVO
$168B
| $3.77M | 1.92% |
+140,000
| New | +$3.84M |
2016 Q2
0 quarters
|
|
19
PUT
Ecolab
ECL
$80.1B
| $3.56M | 1.82% |
+30,000
| New | +$3.5M |
2016 Q2
0 quarters
|
|
|
CELG
20
PUT
DELISTED
Celgene Corp
CELG
| $3.45M | 1.76% |
+35,000
| New | +$3.62M |
2016 Q2
0 quarters
|
|
21
Rigel Pharmaceuticals
RIGL
$881M
| $2.97M | 1.52% |
133,370
-28,320
| -18% | -$704K |
2016 Q1
1 quarter
|
|
22
DELISTED
ChemoCentryx, Inc.
CCXI
| $2.89M | 1.47% |
+642,828
| New | +$2.41M |
2016 Q2
0 quarters
|
|
23
DELISTED
Advanced Accelerator Applications S.A.
AAAP
| $2.85M | 1.45% |
94,177
-79,824
| -46% | -$2.54M |
2015 Q4
2 quarters
|
|
|
24
CALL
Abbott
ABT
$178B
| $2.75M | 1.41% |
+70,000
| New | +$2.79M |
2016 Q2
0 quarters
|
|
25
Bristol-Myers Squibb
BMY
$116B
| $2.75M | 1.41% |
+37,419
| New | +$2.64M |
2016 Q2
0 quarters
|
|
Similar funds
EFL
V
MAM
RCM
AMG
VV
VCP
EHI
Sio Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, Sio Capital Management held 63 positions worth $196M, down 28% from $273M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Sio Capital Management withdrew a net $87.5M in Q2 2016, closing 19 positions and reducing 15 holdings. Its most notable exit was Shire pic, an estimated $10.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 77% a quarter earlier, followed by Miscellaneous and Industrials.
Against the trend, Sio Capital Management opened a new position in Biogen worth $14.8M.
- Sio Capital Management's largest Q2 2016 buy was Biogen: 61,000 shares worth $14.8M.
- Sio Capital Management added most to Cardinal Health in Q2 2016, an estimated $2.85M increase.
- Sio Capital Management's biggest Q2 2016 reduction was McKesson, cutting an estimated $12.9M.
- Sio Capital Management fully exited Shire pic in Q2 2016, selling an estimated $10.9M.
- Sio Capital Management's ten largest holdings make up 56% of its $196M portfolio in Q2 2016.
- Sio Capital Management opened 21 new positions and closed 19 in Q2 2016.
- Sio Capital Management's portfolio value fell 28% quarter-over-quarter to $196M.
Based on Sio Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.